19 februari 2026
51 min
The Sciety Strategy - Navigating Volatility in Life Sciences
BioStock sat down with Andreas Lindblom, co-founder and Managing Partner at Stockholm-based investment firm Sciety, who shared insights on the strategy that has kept Sciety on a steady growth trajectory during 10 years of investing in Nordic life science, despite market turmoil and choppy financial waters. He also revealed the key questions investors should always ask before putting money on the table.
Hosted on Acast. See acast.com/privacy for more information.
Lyssna på fler avsnitt från
Health and Wealth, en podd från BioStock om investeringar i life science
Visar 1–10 av 17 avsnitt
19 december 2025
Från labbgolvet till vd-stolen – han har styrt Genovis i 10 år
52 min
9 april 2025
Cereno Scientific - Science, Synergy & Strategy
56 min
7 mars 2025
I wanted to create a healthcare fund that everyone can invest in
84 min
4 februari 2025
Confessions of a business angel – I listen to Bach and review investment cases
60 min
13 december 2024
On leadership, breaking new ground and Calliditas billion dollar exit
59 min
7 maj 2024
The best years in venture capital overlap perfectly with big crises
76 min
16 april 2024
Earthquakes, investing in drugs and how to be decent in Venture Capital
70 min
9 april 2024
Målet: Förändra världen för hundra miljoner
34 min
19 mars 2024
Clinical trials: What to know before you invest
30 min
18 mars 2024
Chefen är dansk! Søren Bregenholt CEO Alligator Bioscience
44 min